Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 1
2011 2
2012 3
2013 1
2017 1
2018 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Richter's syndrome: Utility of ¹⁸F-FDG PET/CT.
García Vicente AM, Jiménez Londoño GA, Hernández Ruiz B, Soriano Castrejón Á. García Vicente AM, et al. Among authors: hernandez ruiz b. Rev Esp Med Nucl Imagen Mol. 2013 Mar;32(2):102-4. doi: 10.1016/j.remn.2012.08.001. Epub 2012 Oct 6. Rev Esp Med Nucl Imagen Mol. 2013. PMID: 23044071
18F-FDG PET/contrast enhanced CT in the standard follow-up of patients with lymphoma.
García Vicente AM, Talavera Rubio MP, Dominguez Ferreras E, Calle Primo C, Amo-Salas M, Tello Galán MJ, Jiménez Londoño GA, Jiménez Aragón F, Hernández Ruiz B, Soriano Castrejón Á. García Vicente AM, et al. Among authors: hernandez ruiz b. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 May-Jun;37(3):151-155. doi: 10.1016/j.remn.2017.09.003. Epub 2017 Oct 27. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018. PMID: 29107751 English, Spanish.
Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease.
Rosiñol L, García-Sanz R, Lahuerta JJ, Hernández-García M, Granell M, de la Rubia J, Oriol A, Hernández-Ruiz B, Rayón C, Navarro I, García-Ruiz JC, Besalduch J, Gardella S, López Jiménez J, Díaz-Mediavilla J, Alegre A, San Miguel J, Bladé J; PETHEMA/Spanish Myeloma Group. Rosiñol L, et al. Among authors: hernandez ruiz b. Haematologica. 2012 Apr;97(4):616-21. doi: 10.3324/haematol.2011.051441. Epub 2011 Nov 4. Haematologica. 2012. PMID: 22058223 Free PMC article. Clinical Trial.
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients.
Paiva B, Vidriales MB, Mateo G, Pérez JJ, Montalbán MA, Sureda A, Montejano L, Gutiérrez NC, García de Coca A, de las Heras N, Mateos MV, López-Berges MC, García-Boyero R, Galende J, Hernández J, Palomera L, Carrera D, Martínez R, de la Rubia J, Martín A, González Y, Bladé J, Lahuerta JJ, Orfao A, San-Miguel JF; GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Groups. Paiva B, et al. Blood. 2009 Nov 12;114(20):4369-72. doi: 10.1182/blood-2009-05-221689. Epub 2009 Sep 15. Blood. 2009. PMID: 19755674 Free article.
Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.
Lahuerta JJ, Mateos MV, Martínez-López J, Rosiñol L, Sureda A, de la Rubia J, García-Laraña J, Martínez-Martínez R, Hernández-García MT, Carrera D, Besalduch J, de Arriba F, Ribera JM, Escoda L, Hernández-Ruiz B, García-Frade J, Rivas-González C, Alegre A, Bladé J, San Miguel JF. Lahuerta JJ, et al. Among authors: hernandez ruiz b. J Clin Oncol. 2008 Dec 10;26(35):5775-82. doi: 10.1200/JCO.2008.17.9721. Epub 2008 Nov 10. J Clin Oncol. 2008. PMID: 19001321
[PET-CT with intravenous contrast in the evaluation of patients with lymphoma. Contribution to diagnostic indications].
Talavera Rubio MP, García Vicente AM, Domínguez Ferreras E, Calle Primo C, Poblete García VM, Hernández Ruiz B, Bellón Guardia M, Palomar Muñoz A, Cepedello Boiso I, Pilkington Woll P, González García B, Cordero García JM, Molino Trinidad C, Soriano Castrejón A. Talavera Rubio MP, et al. Among authors: hernandez ruiz b. Rev Esp Med Nucl. 2009 Sep-Oct;28(5):235-41. doi: 10.1016/j.remn.2009.04.004. Epub 2009 Jul 31. Rev Esp Med Nucl. 2009. PMID: 19922840 Spanish.
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study.
Lahuerta JJ, Mateos MV, Martínez-López J, Grande C, de la Rubia J, Rosiñol L, Sureda A, García-Laraña J, Díaz-Mediavilla J, Hernández-García MT, Carrera D, Besalduch J, de Arriba F, Oriol A, Escoda L, García-Frade J, Rivas-González C, Alegre A, Bladé J, San Miguel JF; Grupo Español de MM and Programa para el Estudio de la Terapéutica en Hemopatía Maligna Cooperative Study Groups. Lahuerta JJ, et al. Haematologica. 2010 Nov;95(11):1913-20. doi: 10.3324/haematol.2010.028027. Epub 2010 Jul 27. Haematologica. 2010. PMID: 20663944 Free PMC article. Clinical Trial.
18F-FDG-PET/CT in the surveillance of patients with lymphoma: detection of asymptomatic recurrences.
García Vicente AM, Bellón Guardia M, Soriano Castrejón A, Calle Primo C, Cordero García JM, Palomar Muñoz A, Pilkington Woll JP, Talavera Rubio MP, Hernández Ruiz B. García Vicente AM, et al. Among authors: hernandez ruiz b. Rev Esp Med Nucl Imagen Mol. 2012 Jan-Feb;31(1):22-7. doi: 10.1016/j.remn.2011.04.009. Epub 2011 Jul 13. Rev Esp Med Nucl Imagen Mol. 2012. PMID: 21742419 English, Spanish.